Kerri-Ann Millar
Director Financiero/CFO en CUE BIOPHARMA, INC. .
Fortuna: 23 327 $ al 31/05/2024
Cargos activos de Kerri-Ann Millar
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CUE BIOPHARMA, INC. | Director Financiero/CFO | 30/04/2018 | - |
| Comptroller/Controller/Auditor | 01/09/2017 | 21/08/2020 | |
| Contacto de Relaciones con Inversores | 01/09/2017 | - |
Historial de carrera de Kerri-Ann Millar
Antiguos cargos conocidos de Kerri-Ann Millar.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| FLEXION THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/03/2014 | 01/09/2017 |
Formación de Kerri-Ann Millar.
| Boston University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Investor Relations Contact | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CUE BIOPHARMA, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Kerri-Ann Millar
- Experiencia
